MLECW
MLECW 1-star rating from Upturn Advisory

Moolec Science SA Warrant (MLECW)

Moolec Science SA Warrant (MLECW) 1-star rating from Upturn Advisory
$0.01
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/04/2025: MLECW (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -75%
Avg. Invested days 17
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/04/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -0.32
52 Weeks Range 0.01 - 0.07
Updated Date 06/28/2025
52 Weeks Range 0.01 - 0.07
Updated Date 06/28/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -21.69%
Return on Equity (TTM) -174.68%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 897815
Shares Outstanding -
Shares Floating 897815
Percent Insiders -
Percent Institutions -

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Moolec Science SA Warrant

Moolec Science SA Warrant(MLECW) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Moolec Science SA is a biotechnology company focused on developing and producing proteins through cellular agriculture. The company leverages proprietary technology to create animal-free proteins for food and other applications. As a warrant, it represents a right to purchase shares of Moolec Science SA at a specified price within a certain timeframe. Specific founding year and milestones for the warrant itself are not directly applicable as it's a derivative instrument linked to the parent company's lifecycle.

Company business area logo Core Business Areas

  • Protein Production via Cellular Agriculture: Moolec Science aims to produce proteins, such as those found in meat and dairy, without the need for animal agriculture. This involves using genetically modified microorganisms to ferment and produce specific proteins. The technology is intended to offer sustainable and ethical alternatives to traditional protein sources.

leadership logo Leadership and Structure

Information on the specific leadership and structure of 'Moolec Science SA Warrant' as a separate entity is not available. The leadership and structure are that of the underlying company, Moolec Science SA. Further details would require direct consultation of Moolec Science SA's corporate filings.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Protein Ingredients: Moolec Science is developing protein ingredients derived from cellular agriculture. These are intended for use in the food industry to create products like plant-based meats and dairy alternatives. Specific market share data for Moolec Science's protein ingredients is not yet established as they are in the development and early commercialization phases. Competitors in the broader alternative protein market include companies focused on plant-based proteins (e.g., Impossible Foods, Beyond Meat) and other cellular agriculture companies (e.g., Upside Foods, GOOD Meat).

Market Dynamics

industry overview logo Industry Overview

The alternative protein market, including cellular agriculture, is a rapidly growing sector driven by consumer demand for sustainable, ethical, and healthier food options. Key trends include innovation in protein sources, scaling production, regulatory approvals, and consumer acceptance. The market is competitive with established food giants and numerous startups vying for market share.

Positioning

Moolec Science positions itself as an innovator in producing a broad spectrum of animal proteins through its cellular agriculture platform. Its competitive advantages may lie in its proprietary technology for producing various protein types and its focus on cost-effective scalability.

Total Addressable Market (TAM)

The global alternative protein market is projected to reach hundreds of billions of dollars in the coming years. Moolec Science is positioned to capture a portion of this TAM by offering novel protein ingredients for food applications.

Upturn SWOT Analysis

Strengths

  • Proprietary cellular agriculture technology for protein production.
  • Potential for high-volume, sustainable protein manufacturing.
  • Focus on producing a diverse range of animal proteins.

Weaknesses

  • Early-stage company with unproven large-scale commercial viability.
  • Reliance on complex biotechnology and potential for high R&D costs.
  • Need for significant capital investment for scaling production.
  • Uncertainty regarding regulatory approvals for novel food ingredients.

Opportunities

  • Growing consumer demand for sustainable and ethical food alternatives.
  • Expansion into various food categories (meat, dairy, eggs, etc.).
  • Partnerships with major food manufacturers.
  • Advancements in biotechnology and fermentation processes.

Threats

  • Intense competition from plant-based and other alternative protein companies.
  • Potential for public skepticism or resistance to cell-based foods.
  • Challenges in achieving cost parity with traditional animal proteins.
  • Stringent and evolving regulatory landscapes.
  • Technological hurdles in scaling production efficiently.

Competitors and Market Share

Key competitor logo Key Competitors

  • Impossible Foods
  • Beyond Meat
  • Upside Foods
  • GOOD Meat

Competitive Landscape

Moolec Science SA competes in a rapidly evolving alternative protein market. Its key advantages lie in its cellular agriculture approach, aiming to produce a wider range of animal proteins than many plant-based competitors. However, it faces challenges in scaling production, cost, and gaining widespread consumer acceptance compared to more established plant-based alternatives. Competitors like Impossible Foods and Beyond Meat have a head start in market penetration and brand recognition.

Growth Trajectory and Initiatives

Historical Growth: Growth trajectory analysis would apply to Moolec Science SA, focusing on progress in R&D, regulatory milestones, and partnerships. As a warrant, its growth is directly tied to the potential appreciation of the underlying stock.

Future Projections: Future projections for Moolec Science SA would be based on the successful scaling of its cellular agriculture technology and market adoption of its protein products. Analyst estimates for Moolec Science SA would be the primary source.

Recent Initiatives: Recent initiatives for Moolec Science SA would likely involve advancements in their proprietary technology, securing funding, and building strategic partnerships in the food industry.

Summary

Moolec Science SA, through its warrants, represents an investment in a nascent cellular agriculture company. Its strength lies in its innovative technology for producing animal-free proteins, tapping into a growing market for sustainable food. However, it faces significant weaknesses in its early-stage development, high R&D costs, and intense competition. The company must overcome technological and scaling challenges while navigating a complex regulatory environment to capitalize on the substantial market opportunities in alternative proteins. Close monitoring of its technological advancements and market adoption is crucial.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • General industry knowledge of the alternative protein and cellular agriculture markets.
  • Hypothetical data for market share comparison based on industry trends.
  • General understanding of warrants as financial instruments.

Disclaimers:

This JSON output is a hypothetical representation and does not constitute financial advice. Data on market share and specific financial performance are illustrative and may not reflect the actual current state of Moolec Science SA or its competitors. Warrants are complex financial instruments with a high degree of risk. Investors should conduct their own thorough research and consult with a qualified financial advisor before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Moolec Science SA Warrant

Exchange NASDAQ
Headquaters -
IPO Launch date 2023-01-03
CEO -
Sector Healthcare
Industry Biotechnology
Full time employees -
Full time employees -

Moolec Science SA operates as a science-based food ingredient company. The company is based in Grand Cayman, Cayman Islands.